Mitotag

Mitotag is a Portuguese biotech company that develops targeting systems to deliver antioxidants and bioactive molecules directly to cellular mitochondria for protection against oxidative stress. Founded as a spin-off from the University of Porto and the Center for Neuroscience and Cell Biology, the firm operates out of Biocant Park with a focus on delaying aging and treating metabolic disorders through enhanced natural compounds.

• Products: Novel mitochondria-targeted dietary antioxidants designed to accumulate up to 5000 times greater than traditional solutions within specific cellular organelles.
• Services: Medicinal chemistry design, scalable industrial synthesis strategies, and mitochondrial toxicology evaluations for candidate molecules.
• Industries: Anti-aging cosmetics, treatments for liver and neurodegenerative diseases, and anti-aging food supplements specifically formulated for pets.

The company currently executes the TAG2020 investigation program financed by national and EU regional development funds to introduce these innovative antioxidants into new markets.